Assure Holdings (TSXV:IOM) completes its acquisition of Sentry Neuromonitoring

" Assure Holdings (TSXV:IOM) releases first-quarter 2021 financial results

Assure Holdings (IOM) has released its first-quarter 2021 financial results, as well as operational guidance for the upcoming year.
WPD Pharmaceuticals (CSE:WBIO) shows 100 per cent survival may be possible with Annamycin drug

" Entheon Biomedical (CSE:ENBI) provides update on operations and strategic initiatives

Entheon Biomedical (ENBI) has provided updates to several strategic initiatives, including the launch of HaluGen’s Psychedelic Genetic Test kit.
TraceSafe (CSE:TSF) releases wearable-based time and attendance pilot program

" Wellteq Digital Health (CSE:WTEQ) partners with Spanish pharmaceutical marketing company

Wellteq Digital Health (WTEQ) has signed a letter of intent with Frontier Wellness Management and its subsidiary Apotheek Pharma Consulting.
NexTech AR (CSE:NTAR) launches dietitian holograms for supplement line

" Jack Nathan Health Corp. (TSXV:JNH) opening three new medical centres in Walmart Canada Supercentres

Jack Nathan Medical Corp (JNH) has announced three new locations in Western Canada.
BetterLife (CSE:BETR) engages Eurofins CDMO for psychedelic manufacturing

" XORTX (CSE:XRX) welcomes Mr. William “Bill” Farley to the Board of Directors

XORTX Therapeutics (XRX) is pleased to announce the appointment of Mr. William “Bill” Farley to the company’s Board of Directors.
Commonwealth Primary Care ACO and VieMed Healthcare (TSX:VMD) announce an innovative alliance

" CloudMD (TSXV:DOC) closes acquisition of Rxi

CloudMD Software & Services Inc. (DOC) has acquired Rx Infinity Inc., Rxi Pharmacy Inc., and Rxi Health Solutions Inc.
Theratechnologies Inc. (TSX:TH) announces new hires to support its commercial and pipeline assets

" NervGen Pharma (TSXV:NGEN) closes overnight marketed equity offering

NervGen Pharma (NGEN) has closed its previously announced overnight marketed public offering of units.
Claritas Pharmaceuticals (TSX:KLY) forms Nitric Oxide Scientific Advisory Board

" Algernon Pharmaceuticals Inc. (CSE:AGN) announces Ifenprodil reduced Interleukin 6 in Phase 2b/3 COVID study

Algernon Pharmaceuticals announced that NP-120 (Ifenprodil) reduced interleukin 6 (IL-6) in its recent Ifenprodil Phase 2b/3 COVID-19 trial.
Relay Medical (CSE:RELA) subsidiary secures rights to ArtemiC following successful COVID-19 phase II clinical trial

" Synopsis, a VitalHub (TSXV:VHI) subsidiary, wins Technology Company of the Year award

Synopsis, a subsidiary of VitalHub (VHI), has been named “Technology Company of the Year” at the British Data Awards.
Commonwealth Primary Care ACO and VieMed Healthcare (TSX:VMD) announce an innovative alliance

" Cardiol Therapeutics (TSX:CRDL) closes $22 Million bought deal offering

Cardiol Therapeutics (CRDL) has closed its previously announced bought deal offering.